Clinical Trial Update: Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (MyeloMATCH) is evaluating new treatments for newly diagnosed acute myeloid leukemia with an IDH2 gene mutation; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING